Pseudomonas aeruginosa is an opportunistic pathogen and a leading cause of hospital-acquired pneumonia. We identified a 73 kDa protein, designated Pseudomonas exoprotein A (PepA), that was secreted by P. aeruginosa strain PA103. PepA was necessary for in vitro killing of epithelial cells as well as virulence in a mouse model of acute pneumonia. Several properties of PepA suggested that it was secreted by a type III system. Secretion occurred without cleavage of a signal peptide and in low-calcium environments in the presence of a divalent cation chelator, as is the case for characterized P. aeruginosa type III secreted proteins. Secretion of PepA was absent from isogenic mutants with defective type III pathways. Finally, amino-terminal peptide sequence analysis indicated that the amino-terminal five residues of PepA were identical to those of ExoS and ExoT, two type III secreted proteins of P. aeruginosa. After secretion, PepA underwent cleavage at two sites, each with the sequence A-X-K-S, suggesting that the cleavage may be caused by a protease. The gene encoding PepA, designated pepA, was cloned and sequenced, and comparisons with the genetic database using BLAST alignments indicated that the nucleotide sequence of pepA and the inferred protein sequence of PepA had no homology to known sequences. A nucleotide sequence identical to the consensus element for binding of ExsA, a transcriptional activator of P. aeruginosa type III secretion genes, was located 84 bp 5Ј of the translational start codon. Analysis of transposon insertion mutants indicated that the carboxy terminus was required for cytotoxicity. Examination of respiratory clinical isolates demonstrated that pepA was a variable trait and probably acquired by horizontal transmission. Consistent with this hypothesis was the identification of a putative insertion element 94 bp 5Ј of the PepA translational start site. Analysis of G þ C content of the PepA coding sequence and the adjacent insertion element suggested that they were acquired together from a different species. In summary, PepA is a secreted protein of P. aeruginosa that is necessary for epithelial cell cytotoxicity in vitro and virulence in a mouse model of pneumonia.
Introduction
Pseudomonas aeruginosa is the leading cause of nosocomial pneumonia and among the most virulent of the opportunistic pathogens (Salyers and Whitt, 1994) . Up to 75% of all intensive care unit patients are colonized by P. aeruginosa, and the mortality from pneumonia is 50% even with antibiotic treatment (Malangoni et al., 1994) . In addition to its role in nosocomial pneumonia, P. aeruginosa is a frequent cause of septic shock in immunocompromised and burn patients and of bacteraemia in individuals infected with the human immunodeficiency virus (Mendelson et al., 1994; Pittet et al., 1994; McElroy et al., 1995) . It is also the most common cause of corneal ulcers and a contributing factor to severe pulmonary damage and consequent death in patients afflicted with cystic fibrosis (Salyers and Whitt, 1994) .
A remarkable number of bacterial factors have been postulated as playing a role in P. aeruginosa infections, including exoenzyme S (ExoS), exoenzyme T (ExoT), exotoxin A, phospholipase C, alkaline protease, elastase, pili and non-pilus adhesins (Ohman et al., 1980; Woods et al., 1982; 1988; Nicas and Iglewski, 1985a; Woods and Sokol, 1985; Galloway, 1991; Vasil et al., 1991; Prince, 1992) . Two of these factors, ExoS and ExoT, have recently been shown to be secreted by a type III system (Yahr et al., 1996a) . Type III secretion systems are sec-independent protein secretion pathways that are used by many Gramnegative pathogens and are activated by host cell contact (Lee, 1997) . Proteins are secreted without cleavage of a signal peptide, although the information for secretion is located in the amino-terminal portion of the protein. In addition to P. aeruginosa, Salmonella, Shigella, Yersinia, enteropathogenic Escherichia coli and many other Gramnegative pathogens use conserved type III systems to secrete proteins thought to be virulence factors (Lee, 1997) .
A number of animal models and in vitro assays have been developed to examine the relevance of Pseudomonas products in both acute and chronic infections (Woods et al., 1982; Wiener-Kronish and Broaddus, 1993; Apodaca et al., 1995; van Doorninck et al., 1995; Tang et al., 1996) . A particularly useful in vitro assay developed by Apodaca et al. (1995) quantitates the cytotoxic capacity of P. aeruginosa isolates inoculated onto polarized Madin-Darby canine kidney (MDCK) cells. Cytotoxicity measured by this assay has been shown to correlate with virulence in a rabbit model of acute pneumonia Kudoh et al., 1994; Apodaca et al., 1995) . We have reported previously that the use of the MDCK cell cytotoxicity assay to screen a transposon insertion library of P. aeruginosa strain PA103 resulted in the identification of 33 noncytotoxic mutants (Kang et al., 1997) . Several of these mutants were defective in the secretion of one or more proteins. In this paper, we characterize one of these proteins, designated Pseudomonas exoprotein A (PepA), and show that it is required for the cytotoxicity of MDCK epithelial cells and is a virulence factor in a mouse model of acute pneumonia.
Results

Characterization of PepA
Previous characterization of non-cytotoxic mutants identified by screening a transposon mutant library of P. aeruginosa strain PA103 indicated that several were defective in the secretion of a number of proteins (Kang et al., 1997) . Most of these non-cytotoxic mutants failed to secrete several proteins, suggesting a defect in a secretion mechanism. However, two of them, mutants 8 and 13, appeared to have a secretion defect limited to a specific protein of approximately 73 kDa, which was designated PepA. Depending upon growth and processing conditions, this protein either appeared as a single band corresponding to a size of 73 kDa or as a triplet corresponding to sizes of 73, 71 and 69 kDa under conditions of SDS-PAGE (Fig. 1A) . Whereas mutant 8 did not secrete the 73 kDa protein (Fig. 1A and B, lane 4), mutant 13 secreted a protein that was immunologically related to PepA but migrated slightly faster under conditions of SDS-PAGE ( Fig. 1A and B, lane 5, and Fig. 1C ). The correlation between decreased cytotoxicity and aberrant secretion of PepA in these mutants suggested a causative role for this protein in epithelial cell killing.
PepA was purified as described previously (Hauser et al., 1998) . Amino-terminal sequence analysis of the 73 kDa protein indicated that the first five residues of this protein were identical to ExoS and ExoT, type III secreted proteins of Pseudomonas (Yahr et al., 1996b) (Table 1) . Differences in subsequent residues, however, indicated that the 73 kDa protein was distinct from these proteins. The initial residue of secreted PepA was a methionine, indicating that cleavage of a signal peptide is not essential for secretion. Both of the above findings are consistent with the secretion of PepA by a type III pathway. Amino-terminus peptide sequencing was also performed on the 71 and 69 kDa ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 Fig. 1 . Analysis of secreted proteins of strain PA103 and mutants. Samples of culture supernatants were prepared and electrophoresed on polyacrylamide gels as described in the text. A. Proteins were visualized by staining with Coomassie brilliant blue. Lane 1, molecular weight standards; lane 2, PA103 grown in MINS medium; lane 3, PA103 grown in MINSC medium; lane 4, mutant 8; lane 5, mutant 13; lane 6, mutant N, lane 7, PA103exsA::⍀. B. Immunoblot analysis using polyclonal PepA antisera. The lane order is the same as in (A). The location of bands corresponding to PepA are indicated on the right-hand side. PA103 supernatants contain appreciable amounts of PepA and two slightly faster migrating immunologically cross-reactive proteins shown to be cleavage products of PepA. Mutant 13 supernatants contain only a single protein, which migrates slightly faster than PepA and is immunologically cross-reactive with PepA. C. For maximum resolution, proteins of interest were partially purified and electrophoresed to the bottom of an SDS-polyacrylamide gel and visualized by silver staining. PepA secreted from PA103 (lane 1) migrates slightly faster than PepA secreted from mutant 13 (lane 2). The sizes of the molecular weight standards are indicated on the left-hand side of (A).
proteins (Table 1) , which were purified similarly to PepA. The initial residues of the 71 and 69 kDa amino-terminal peptide sequences were indeterminate. Therefore, we were unable to ascertain whether each of these proteins began with a methionine.
PepA secretion
The secretion of PepA under various growth conditions was examined. ExoS and ExoT, the two characterized type III secreted proteins of P. aeruginosa, are secreted in vitro when bacteria are grown in the absence of calcium and the presence of nitrilotriacetic acid (NTA), a divalent cation chelator (Thompson et al., 1980) . As PepA secretion was postulated to occur by way of the same system as ExoS and ExoT, it was examined under similar conditions. PA103 was grown in minimal media supplemented with NTA and lacking calcium (MINS; Nicas and Iglewski, 1984) and in minimal media supplemented with calcium and lacking NTA (MINSC). Supernatants were partially purified, concentrated by ammonium sulphate precipitation and subjected to SDS-PAGE and immunoblot analysis ( Fig. 1A and B, lanes 2 and 3). Antibodies against purified PepA, which were prepared as described in Experimental procedures, were used. As with ExoS and ExoT, PepA is not secreted when bacteria are grown in the presence of calcium and in the absence of NTA. Relatively large amounts of the protein, however, were present in the supernatants of bacteria grown in media that lacked supplemental calcium but contained NTA.
To test the hypothesis that PepA is secreted by a type III pathway further, the secretion of a mutant defective in this pathway was examined. Mutant N (Kang et al., 1997) is derived from PA103 but contains a Tn5 transposon insertion in pscJ, a gene that is thought to encode a part of the type III secretion apparatus normally located in the outer membrane of P. aeruginosa (Yahr et al., 1996a) . It is thus defective in the secretion of ExoT and other proteins thought to be targets of the type III system (Hauser et al., 1998) . PepA was not detected in supernatants of cultures of mutant N by Coomassie brilliant blue staining of SDS-polyacrylamide gels or by immunoblot analysis (Fig. 1A and B, lane 6), although the protein was easily visualized in supernatants from the wild-type PA103 strain.
Genes of the type III secretion system of P. aeruginosa require the transcriptional activator ExsA for full expression Yahr et al., 1995; 1996a) . We, therefore, analysed broth supernatants of PA103exsA::⍀, a derivative of PA103 that contains an insertion within the gene encoding ExsA. SDS-PAGE and immunoblot analysis failed to detect evidence of secreted PepA in these supernatants (Fig. 1A and B, lane 7), indicating that ExsA is necessary for PepA secretion.
Cloning of the gene encoding PepA As stated above, mutant 8, a non-cytotoxic mutant of PA103, did not secrete PepA. This mutant, however, did secrete ExoT and thus appeared to have an intact type III secretion apparatus (Hauser et al., 1998) . These findings were consistent with the insertion of the mutant 8 transposon into the PepA structural gene, designated pepA, although other explanations are also possible. To clone this gene, mutant 8 was mated with a cosmid library consisting of PA103 genomic DNA in an Escherichia coli background, and the exconjugants were screened for cytotoxicity. Two cosmids, 6-1-D and 6-4-B, were capable of complementing mutant 8 to a cytotoxic phenotype. 6-1-D was analysed further. Quantitative [ 14 C]-inulin permeability assays demonstrated that mutant 8 containing cosmid 6-1-D was complemented to a cytotoxic phenotype (Fig. 2) . (The increased cytotoxicity of this exconjugant relative to wild-type PA103 may be caused by a gene dosage effect.) Cosmid 6-1-D DNA was purified and digested with several restriction endonucleases, and a partial restriction map was generated. pepA was localized to a 3.8 kb BamHI-EcoRI fragment of the cosmid (Fig. 3) , as described in Experimental procedures. This fragment was cloned into the broad-host-range vector pLAFRSK1, and the resulting construct was designated pAH807.
Quantitative [ 14 C]-inulin permeability assays demonstrated that pAH807 complemented the phenotype of mutant 8 to cytotoxicity ( Fig. 2A) . Again, the increased cytotoxicity of mutant 8 harbouring this plasmid relative to PA103 may be caused by a gene dosage effect. Mutant 8 harbouring pAH807 also secreted PepA into the medium under inducing conditions (i.e. growth in MINS; Fig. 2B ). Thus, we conclude that the 3.8 kb BamHI-EcoRI fragment of pAH807 contains pepA as well as a locus necessary for complementation of the phenotype of mutant 8 to cytotoxicity. Of interest, mutant 8 harbouring pepA-containing plasmids appeared to secrete relatively decreased amounts of several other proteins. One possible explanation is that the presence of multiple copies of pepA results in increased expression and secretion of PepA, which in turn limits the expression and secretion of other proteins.
ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 Table 1 . Amino-terminal peptide sequences.
Protein
Amino-terminal peptide sequence Kulich et al. (1994) . b. Yahr et al. (1996b) .
Nucleotide sequence analysis of the pepA Both strands of the entire 3.8 kb BamHI-EcoRI fragment of pAH807 were sequenced. One complete large open reading frame (ORF) and part of a second large ORF were contained in the fragment ( Fig. 3 ; ORFs are designated 'PepA' and 'IS'). The nucleic acid sequence of the complete ORF (nucleotides 798-2861 of the submitted sequence) was consistent with a gene encoding a 73 890 kDa protein with an inferred amino terminus identical to that of PepA (Fig. 4) . We thus identify this ORF as pepA. This gene was preceded by a potential Shine-Dalgarno sequence (AGGAGCG) positioned three bases before the start codon. Peptide sequences identical to the amino termini of the 71 kDa and 69 kDa proteins were also noted within the inferred protein sequence of PepA (Fig. 4) , indicating that these proteins are cleavage products of PepA. Interestingly, in both cases, the cleavage occurred after a lysine in the sequence A-X-K-S, suggesting that this may be the recognition site of a protease. Comparison of the sequence of the 3.8 kb BamHI-EcoRI fragment with the sequences adjacent to the transposons in mutants 8
ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 (Fig. 1A and B, lane 5, and Fig. 1C ). In contrast, the transposon in mutant 8 had inserted 125 bases 3Ј of the pepA start codon (Fig. 4) , within the coding sequence (between nucleotides 923 and 924 of the submitted sequence). It is, therefore, not surprising that this mutant did not secrete detectable levels of PepA.
The nucleotide sequence upstream of pepA provided further evidence that this gene is part of a type III secretion system. A nucleotide sequence identical to the ExsA consensus element (TXAAAAXA; Hovey and Frank, 1995) was located 84 bases 5Ј of the translational start codon (nucleotides 714-721 of the submitted sequence). Such elements are usually located 51 or 52 bases upstream of the transcriptional start site of P. aeruginosa type III secretion genes and operons Goranson and Frank, 1996) . A transcriptional start site at this location would define a ¹10 promoter element of TAATAT (bases 758-763 of the submitted sequence), which compares favourably with the E. coli 70 consensus ¹10 promoter sequence of TATAAT (McClure, 1985) . Such placement, however, defines a ¹35 promoter element of CAAAAC (bases 735-740 of the submitted sequence), which does not resemble the E. coli 70 consensus ¹35 promoter sequence. Homology searches using BLAST alignments indicated that pepA is novel and does not show significant similarity to other genes or proteins in the database. The G þ C content of this gene was 59%, distinct from that of the P. aeruginosa genome (67.2%; Palleroni, 1984) and the pscB-L locus (67.5%), which encodes proteins comprising the Pseudomonas type III secretion apparatus (Yahr et al., 1996a) . However, the nucleotide sequence of the 5Ј incomplete ORF ( Fig. 3 ; bases 1-661 of the submitted sequence) was closely related to several insertion elements found in Gram-negative bacteria. In particular, this partial nucleotide sequence was similar to IS1209 of P. aeruginosa strain PAO1 (83% identity), IS407 of P. cepacia (64% identity) and IS476 of Xanthomonas campestris (61% identity). The G þ C content of the sequenced portion of the insertion element was 60%, very similar to that of pepA but distinct from that of the P. aeruginosa genome.
Virulence in a mouse model of acute pneumonia Prior studies have indicated that PA103exsA::⍀, which does not secrete type III effector molecules or PepA, was ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 less virulent in an animal model of acute pneumonia than wild-type PA103 Kudoh et al., 1994; McElroy et al., 1995; Sawa et al., 1997) . The virulence of PepA was therefore tested in a mouse model of acute pneumonia . Approximately 5 × 10 7 colony-forming units (cfu) of PA103, PA103exsA::⍀, mutant 8 (which does not secrete PepA), mutant 8 complemented with pAH807 (a plasmid containing a wild-type copy of pepA) and mutant 8 harbouring pLAFR5SK1 (the broad-host-range vector used to construct pAH807 but lacking pepA) were instilled into the lungs of BALB/c mice. Mortality was observed over the next 7 days. These experiments were performed twice; representative results are shown in Table 2 . As expected, all five mice infected with PA103 died within the first 72 h after instillation, whereas four of the five mice infected with PA103exsA::⍀ were still alive 7 days after infection. Interestingly, all five mice infected with mutant 8 remained alive throughout the 7 days after instillation, indicating that the decreased cytotoxicity of this mutant in vitro correlated with decreased virulence in the mouse model. Three of the five mice infected with mutant 8 complemented with pAH807 died within 72 h, whereas all of the mice instilled with mutant 8 complemented with the pLAFR5SK1 vector alone were still alive after 7 days. We suspect that we failed to observe 100% mortality with mutant 8 complemented with pAH807 because of plasmid loss in the mice, where antibiotic selection was absent. At both time points, there was a statistically significant mortality difference between animals receiving bacteria containing an intact PepA gene and those receiving bacteria with a mutated PepA gene. These findings indicate that PepA is necessary for virulence in a mouse model of acute Pseudomonas pneumonia.
Clinical isolates
The confirmation of the role of PepA in virulence and epithelial cell cytotoxicity prompted an examination of P. aeruginosa clinical isolates for secretion of this protein and the presence of the gene that encodes it. Ten consecutive respiratory isolates of P. aeruginosa collected from different patients at the Moffit-Long Hospital at the University of California, San Francisco (UCSF) were obtained.
Isolates from patients with cystic fibrosis were excluded, because we wished to focus on acute P. aeruginosa pneumonia rather than the chronic pneumonia associated with this disease. Bacteria were grown under conditions that induce the secretion of PepA, and culture supernatants were concentrated and partially purified by ammonium sulphate precipitation. Immunoblot analysis with polyclonal PepA antisera indicated that four of the isolates, 616982, 617000, 633195 and 633344, secreted detectable amounts of PepA (Fig. 5A ).
To determine whether the isolates that did not secrete PepA were deficient in this property because of regulatory differences or because they lacked the gene encoding this protein, each isolate was analysed using Southern hybridizations of chromosomal DNA digested with BamHI. An internal 1.6 kb SmaI-Sal I fragment of pepA was used as a probe (Fig. 3) . The results indicated that the six isolates that did not secrete detectable amounts of PepA also did not contain the gene encoding this protein (Fig.  5B ). These findings indicate that pepA is a variable trait among clinical respiratory isolates of P. aeruginosa.
Discussion
In this paper, we describe PepA, a virulence factor of P.
ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 5 . Secretion of PepA and the presence of pepA in 10 consecutive respiratory isolates of P. aeruginosa. Culture supernatants were prepared as described in the text, and immunoblot analysis was performed using PepA antisera. The designations of the clinical isolates are shown across the top of (A), and the location of bands corresponding to PepA are indicated on the right-hand side of (A). Some samples contain only PepA, while others also contain the 71 kDa and 69 kDa cleavage products. B. Southern hybridization analysis of chromosomal DNA digested with BamHI using a radiolabelled internal pepA DNA fragment as a probe. The location of the 12 kb molecular weight standard is indicated on the right-hand side.
aeruginosa that is required for bacterial-mediated epithelial cell damage in vitro and for virulence in an animal model of acute pneumonia. The gene encoding this protein was identified by screening a library of transposon insertion mutants for the loss of cytotoxicity when applied to the apical surface of MDCK cell monolayers. The demonstration that PepA is indeed required for virulence in a mouse model of acute pneumonia validates this approach and, moreover, suggests that the use of MDCK cell cytotoxicity assays may be valuable in the identification of virulence factors of cytotoxic pathogens other than P. aeruginosa. Several properties of PepA are consistent with secretion via a type III pathway. First, secretion of PepA occurred in the absence of cleavage of a signal peptide, as is characteristic of type III proteins (Lee, 1997) . Secondly, secretion occurred under environmental conditions (i.e. the presence of the divalent cation chelator NTA) known to induce Pseudomonas type III secretion (Yahr et al., 1996a) . Thirdly, two PA103 mutants (mutant N and PA103exsA::⍀) defective in type III transport did not secrete PepA. Mutant N harbours a transposon insertion in a gene, pscJ, which encodes a structural component of the type III secretion apparatus (Yahr et al., 1996a) . Likewise, PA103exsA::⍀ does not express a transcriptional activator necessary for the initiation of type III gene transcription (Goranson and Frank, 1996) . Neither mutant secreted PepA, suggesting that an intact type III system is essential for the secretion of this protein. Finally, the first five amino acids of PepA were identical to those of ExoS and ExoT, two other proteins of P. aeruginosa that are translocated by a type III pathway. In the case of ExoS, the information necessary and sufficient for secretion by the type III pathway is contained in the amino-terminal nine residues (Yahr et al., 1996a) . The identity of the first five amino acids of ExoS and PepA indicates that PepA may also contain this information. Together, these findings suggest that PepA is secreted by a type III pathway.
As stated above, the transcriptional activator ExsA regulates the expression of all P. aeruginosa type III secretion operons examined to date Yahr et al., 1995; 1996a) , including the genes encoding the secreted proteins ExoS and ExoT. Therefore, it is of interest that PepA synthesis also appears to be regulated by ExsA. In addition, a sequence identical to the consensus ExsA binding site was located upstream of the pepA coding region. ExsA binding sites are usually located 51-52 bp upstream of the transcription initiation site . Further studies are ongoing to demonstrate the actual transcriptional start site of pepA and to define further the role of ExsA in its regulation.
PepA is necessary for the cytotoxicity of P. aeruginosa. This finding is in agreement with that of Fleiszig et al. (1997) who noted that the presence of an approximately 70 kDa secreted protein, presumably PepA, correlated with the level of cytotoxicity of P. aeruginosa clinical isolates. As PepA is not secreted by PA103exsA::⍀, it may be the factor responsible for the decreased cytotoxicity of this mutant relative to wild type in the assays performed by Apodaca et al. (1995) . Although the function of PepA cannot be inferred from its amino acid sequence, we hypothesize that PepA is a cytotoxin. The type III secretion system of P. aeruginosa is most closely related to that of Yersinia (Yahr et al., 1996a) , which secretes three types of molecules: effector proteins, regulatory proteins and factors that translocate the effector proteins into the cytoplasmic compartment of eukaryotic cells (Lee, 1997) . PepA has no similarity to the regulatory proteins (e.g. LcrE) of the Yersinia system. Homologues to YopB and YopD, the Yersinia molecules that translocate effector proteins across eukaryotic cell membranes, have recently been identified in P. aeruginosa (Hauser et al., 1998) and are distinct from PepA. Effector proteins, however, tend to be less well conserved than other components of type III systems and are thought to have evolved to meet the needs of the individual pathogen. We, therefore, suspect that PepA is an effector molecule with cytotoxic activity and are currently investigating whether PepA is found within the cytoplasm of eukaryotic cells. Currently, however, the possibility that PepA has an indirect effect on the ability of P. aeruginosa to be cytotoxic cannot be ruled out.
In addition to being necessary for in vitro cytotoxicity, PepA was important in the pathogenesis of acute pneumonia in a mouse model. PepA may cause cell cytotoxicity in vivo as well as in vitro, and the resulting tissue damage may explain the role of PepA in pneumonia. This hypothesis is supported by studies performed by Kudoh et al. (1994) and Apodaca et al. (1995) , which indicate that virulence in animal models of acute P. aeruginosa pneumonia correlates with the in vitro cytotoxicity of the infecting strain. The absence of pepA in six of the 10 respiratory isolates of P. aeruginosa examined suggests that some of the strains were merely colonizing the respiratory tract or that Pseudomonas factors other than PepA are also important in the pathogenesis of this disease. Further studies will be necessary to determine if PepA is also important in chronic pneumonia observed in patients with cystic fibrosis and in P. aeruginosa infections involving other sites, such as the urinary tract, the cornea and the damaged skin of burn patients. It is of interest to note that, as PepA is not secreted by PA103exsA::⍀, it may be responsible for the phenotypes noted in the many other studies that used this mutant. These include a mouse model of burn infections (Nicas and Iglewski, 1985b) and rabbit and rat models of acute pneumonia Kudoh et al., 1994; McElroy et al., 1995; Sawa et al., 1997) .
Two additional properties of PepA may be important. First, processing of the amino terminus occurred, perhaps by a protease that recognizes an Ala-X-Lys-Ser sequence and cleaves between the lysine and the serine. The relevance of this cleavage to the function and cellular localization of PepA awaits further analysis, but it was noted that the truncated form of PepA secreted by mutant 13 did not undergo significant amounts of cleavage (data not shown) and was also associated with decreased cytotoxicity. Secondly, the carboxy terminus of PepA is required for cytotoxicity. Mutant 13, which harbours a transposon insertion 88 nucleotides from the pepA stop codon, secretes a stable protein but is defective in its ability to kill MDCK cells (Kang et al., 1997) . If PepA is a functional cytotoxin, this may mean that its carboxy terminus contains the functionally active domain, although other interpretations (e.g. that this portion of the protein is necessary for translocation into eukaryotic cells) are also possible.
Several observations suggested that pepA was acquired by horizontal transmission from a different source or at a different time from the genes encoding the secretion apparatus of the P. aeruginosa type III system. The G þ C content of the pepA coding region was 59%, compared with 67.2% for the P. aeruginosa genome (Palleroni, 1984) and 67.5% for the pscB-L locus (Yahr et al., 1996a) , which encodes structural components of the P. aeruginosa type III secretion apparatus. Remarkably, a putative insertion element was noted just 94 bp 5Ј to pepA, which had approximately the same G þ C content (60%) as pepA, suggesting that this gene is or was part of a mobile genetic element. In six out of 10 clinical isolates examined, pepA was absent, and yet the type III secretion system was intact and functional, as shown by the secretion of detectable levels of ExoT (data not shown). Thus, although a type III pathway appears to secrete PepA, the gene that encodes it may have been acquired distinct from this system. In this respect, pepA is similar to exoS, the gene encoding ExoS, which has also been shown to be a variable trait in P. aeruginosa clinical isolates . Characterization of the sequences surrounding pepA and its associated insertion element may elucidate the relationships between these factors further and demonstrate whether pepA is part of a larger pathogenicity island.
Subsequent to the submission of this article, FinckBarbançon et al. (1997) reported the cloning, sequencing and characterization of ExoU, a P. aeruginosa secreted protein. Expression of this protein was shown to correlate with cytotoxicity and acute lung injury in mice. In addition, these investigators also showed that not all clinical isolates contained the gene encoding ExoU. Comparison of inferred amino acid sequence data indicate that PepA and ExoU are the same protein.
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Experimental procedures
Bacterial strains, plasmids and media Bacterial strains and plasmids used in this study are listed in Table 3 . P. aeruginosa strains were cultured routinely in Luria-Bertani (LB) broth or in Vogel-Bonner minimal media (VBM) (Vogel and Bonner, 1956 ) with antibiotics as needed. For the analysis of extracellular proteins, P. aeruginosa strains were grown in a defined minimal medium optimized for ExoS production (MINS; 25 mM KH 2 O 4 , 95mM NH 4 Cl, 50 mM monosodium glutamate, 110 mM disodium succinate, 10 mM trisodium NTA, 2.5% glycerol, 5 mM MgSO 4 and 18 M FeSO 4 ; Nicas and Iglewski, 1984) . MINSC was identical to MINS except that NTA was omitted and 2 mM CaCl 2 was added. Antibiotics were used at the following concentrations: ampicillin, 100 g ml
¹1
; tetracycline, 20 g ml ¹1 for E. coli and 100 g ml ¹1 for P. aeruginosa; gentamicin, 10 g ml ¹1 for E. coli and 100 g ml ¹1 for P. aeruginosa.
Protein analysis
For the analysis of extracellular proteins, P. aeruginosa strains were grown in MINS medium unless otherwise indicated for approximately 17 h at 37ЊC with vigorous shaking. Supernatants were prepared from 5 ml of culture by centrifugation at 6000 × g at 4ЊC for 20 min. Proteins present in supernatants were precipitated by the addition of ammonium sulphate (55% final concentration). After incubation on ice for 2 h, the precipitated material was isolated by centrifugation at 13 000 × g at 4ЊC for 20 min. The pellet was boiled in 500 l of SDS-PAGE sample buffer for 5 min, and 20 l of each sample was electrophoresed on an 8% SDS-polyacrylamide gel (Laemmli, 1970) . Proteins were detected using Coomassie brilliant blue staining.
PepA purification was performed as follows. Briefly, PA103 was grown in MINS at 37ЊC with shaking for approximately 17 h. Extracellular protein aggregates, which consist of secreted proteins, were physically removed from 5 ml bacterial broths using sterile streaking loops, washed once in 10 mM NaCl and solubilized in SDS sample buffer. After boiling for 5 min, samples were electrophoresed on 8% SDS-polyacrylamide gels. Proteins were visualized by silver staining. For aminoterminal peptide sequence analysis, the electrophoresed aggregate proteins were electroblotted onto polyvinylidene fluoride membranes (Applied Biosystems) for subsequent aminoterminal sequencing (Applied Biosystems Model 470A Protein Sequencer) by the Biomolecular Resource Center at UCSF.
Antibodies and immunoblot analysis
Polyclonal rabbit antisera against PepA was prepared as follows. PepA was purified from macromolecular aggregates as described above. After SDS-PAGE, PepA was excised from the acrylamide gel and extracted according to the method of Hager and Burgess (1980) . Rabbit injections and bleeds were performed by Animal Pharm Services. For immunoblot analysis, proteins were electrotransferred from SDS-polyacrylamide gels to nitrocellulose (Schleicher & Schuell) and hybridized with PepA antiserum (Sambrook et al., 1989) . Goat anti-rabbit IgG horseradish peroxidase conjugate (Gibco BRL) diluted 1:5000 was used as a secondary antibody. Detection was performed using the ECL Western blotting system (Amersham).
Cosmid library preparation and bacterial conjugation A cosmid library of PA103 genomic DNA was constructed as follows. Purified chromosomal DNA from PA103 was partially digested with Sau 3A. DNA fragments between 25 and 40 kb were isolated and purified by extraction from 0.4% agarose gels. The 3Ј overhangs were partially filled in by incubation with the Klenow fragment (Gibco-BRL) in the presence of dGTP and dATP. These fragments were then ligated with pLAFR5SK1 that had been previously digested with XhoI and incubated with the Klenow fragment in the presence of dTTP and dCTP. (The Klenow treatment prevented selfligation of the genomic DNA fragments and the vector.) Ligated constructs were transduced into Escherichia coli strain S17-1 using a phage packaging kit (Stratagene Corp.). E. coli-harbouring cosmids were selected by growth on tetracycline-containing agar. A total of 1536 individual cosmid clones were isolated.
Cosmids were conjugated into Pseudomonas by mating host E. coli strain S17-1 harbouring the desired vector with the appropriate mutant or strain. For example, S17-1 harbouring pAH807 was mated with P. aeruginosa mutant 8 for complementation studies by cross-streaking of the two strains on LB agar and subsequently selecting for exconjugants by growth on VBM agar (which does not support the growth of E. coli ) supplemented with tetracycline, the antibiotic selection marker contained on the cosmid.
Cytotoxicity assays
To identify cytotoxic exconjugants qualitatively, trypan blue exclusion assays were performed on MDCK cell monolayers as described previously (Kang et al., 1997) . [ 14 C]-Inulin permeability assays were used to quantitate cytotoxicity and were also performed as described previously (Kang et al., 1997) , except that bacteria were grown in MINS with shaking before use in the assay.
Southern hybridization analysis
Chromosomal DNA was isolated according to the method of Chen and Kuo (1993) , and cosmid DNA was isolated using the alkaline lysis method (Sambrook et al., 1989) . DNA was digested with the appropriate restriction endonucleases, electrophoresed on agarose gels (0.8%) and transferred to nylon membranes (Hybond-N; Amersham). Hybridizations were performed in 6 × SSC (SSC is 0.15 M NaCl and 0.015 M sodium citrate), 0.5% SDS at 68ЊC as described by Sambrook et al. (1989) . Blots were washed in 2 × SSC, 0.1% SDS, for 15 min at 27ЊC followed by a wash in 0.1 × SSC, 0.5% SDS, for 30 min at 37ЊC. A final wash was performed with 0.1 × SSC, 0.5% SDS, for 30 min at 68ЊC. Bands were visualized by autoradiography.
Cloning of PepA
The gene encoding PepA was cloned by complementing the phenotype of mutant 8 to cytotoxicity using a cosmid library ᮊ 1998 Blackwell Science Ltd, Molecular Microbiology, 27, 807-818 of PA103 genomic DNA in E. coli strain S17-1. E. coli harbouring cosmid clones was mated with mutant 8 in pools of eight, and the resulting exconjugant Pseudomonas pools were screened for cytotoxicity on MDCK cell monolayers by trypan blue exclusion assays. Each member from pools able to complement to cytotoxicity was then individually mated with mutant 8, and the exconjugants were tested for cytotoxicity. Two cosmid clones, 6-1-D and 6-4-B, were able to complement the phenotype of mutant 8 to cytotoxicity.
The portion of cosmid 6-1-D that contained pepA was identified by oligonucleotide hybridization analysis as follows. Mutant 13 appeared to secrete a truncated form of PepA (Fig. 1A and B, lane 5, and Fig. 1C ). The possibility of aminoterminal modification was ruled out by peptide sequence analysis, which indicated that the first five residues of this protein were identical to PepA (data not shown). Therefore, it appeared that the carboxy terminus of this protein was modified, most probably because of insertion of the transposon into the 3Ј portion of pepA. A 130 bp DNA fragment corresponding to this insertion site was used as a probe to identify the carboxy terminus-encoding portion of pepA. The fragment, obtained by performing inverse PCR sequencing on mutant 13 as described previously (Kang et al., 1997) , was radiolabelled by nick translation (Sambrook et al., 1989) . Likewise, a degenerate oligonucleotide corresponding to the amino terminusencoding portion of pepA (5Ј-CCCAAGCTTATGCA
[C/T]AT-[A/C/T]CA[A/G][A/T][C/G][A/C/G/T][C/T]T-3Ј, synthesized
by Operon Technologies) was synthesized and end labelled. It was assumed that these two probes would approximate the boundaries of the structural gene. Southern hybridization analysis of the two labelled probes to digested cosmid 6-1-D DNA localized pepA to a 3.8 kb BamHI-EcoRI DNA fragment (Fig. 3) . This fragment was ligated into pBR322 previously digested with BamHI and EcoRI, and the resulting construct, designated pAH806, was transformed into E. coli strain XL1-Blue. A chimeric vector competent for maintenance in P. aeruginosa was constructed by digesting pAH806 and the broad-host-range vector pLAFR5SK1 with BamHI and ligating the two together. This construct, designated pAH807, was transduced into E. coli strain S17-1 and used for subsequent mating experiments.
Nucleotide sequence analysis
The 3.8 kb BamHI-EcoRI DNA fragment was digested with SmaI, EcoRI and Sal I to yield a 1.15 kb BamHI-SmaI fragment, a 0.65 kb SmaI-EcoRI fragment, a 0.95 kb EcoRI-Sal I fragment and a 1.1 kb Sal I-EcoRI fragment (Fig. 3) . Each fragment was cloned into appropriately digested M13mp18 and M13mp19 vectors using standard techniques (Sambrook et al., 1989) and sequenced (Applied Biosystems model 377 automated DNA sequencer) by the Biomolecular Resource Center at UCSF. Sequence analyses were performed using the GCG (Genetics Computer Group, WI, USA) software package (Devereux et al., 1984) . BLAST searches of GenBank were performed through GCG. Nucleotide sequences have been deposited in GenBank under the accession number AF027291.
Mouse model of acute pneumonia
Bacteria were tested in a mouse model of acute pneumonia developed by Sawa et al. (1997) . After growth in MINS for 17 h at 37ЊC in a shaker incubator, bacteria were collected by centrifugation, washed twice with phosphate-buffered saline (PBS) and resuspended in PBS. Appropriate bacterial concentrations were determined by spectrophotometry and confirmed by the plating of serial dilutions. Approximately 5 × 10 7 cfu of bacteria in a volume of 50 l were instilled into the lungs of anaesthetized BALB/c mice through a bluntended needle (Fisher) used for intubation. Mice were monitored for survival over the subsequent 7 days. The association between an intact pepA allele and lethality was analysed for statistical significance at both 72 h after infection and 7 days after infection using the chi-square test.
